Elevance Health Inc [NYSE: ELV] price plunged by -11.50 percent to reach at -$45.51.
The one-year ELV stock forecast points to a potential upside of 28.72. The average equity rating for ELV stock is currently 1.70, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Elevance Health Inc [ELV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELV shares is $491.39 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELV stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Elevance Health Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 15, 2025. The new note on the price target was released on March 17, 2025, representing the official price target for Elevance Health Inc stock. Previously, the target price had yet another drop from $520 to $440, while Stephens kept a Equal-Weight rating on ELV stock.
The Price to Book ratio for the last quarter was 1.86. Price to Free Cash Flow for ELV in the course of the last twelve months was 21.54.
ELV Stock Performance Analysis:
Elevance Health Inc [ELV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.32. With this latest performance, ELV shares dropped by -7.11% in over the last four-week period, additionally sinking by -5.61% over the last 6 months – not to mention a drop of -5.06% in the past year of trading.
Insight into Elevance Health Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Elevance Health Inc [ELV] shares currently have an operating margin of 4.82%. Elevance Health Inc’s Net Margin is presently recorded at 3.23%.
Return on Equity for this stock inclined to 5.11%, with Return on Assets sitting at 5.11%.
ELV Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elevance Health Inc go to 10.60%.
Elevance Health Inc [ELV] Institutonal Ownership Details
The top three institutional holders of ELV stocks are: VANGUARD GROUP INC with ownership of 21.21 million shares, which is approximately 9.133%. BLACKROCK INC., holding 20.7 million shares of the stock with an approximate value of $$11.22 billion in ELV stocks shares; and BLACKROCK INC., currently with $$6.31 billion in ELV stock with ownership which is approximately 5.0157%.
